Ryutaro Yano

Optogenetic astrocyte activation evokes BOLD fMRI response with oxygen consumption without neuronal activity modulation

Norio Takata, Yuki Sugiura, Keitaro Yoshida et al. · Glia · 2018 · 103 citations

Dysfunction of ventrolateral striatal dopamine receptor type 2-expressing medium spiny neurons impairs instrumental motivation

Iku Tsutsui‐Kimura, Hiroyuki Takiue, Keitaro Yoshida et al. · Nature Communications · 2017 · 56 citations · Full text

Quantitative temporal changes in DTI values coupled with histological properties in cuprizone-induced demyelination and remyelination

Ryutaro Yano, Junichi Hata, Yoshifumi Abe et al. · Neurochemistry International · 2017 · 46 citations

Neurophysiology, Neuroanatomy, Medicine +9

Parkinson Disease: Diffusion MR Imaging to Detect Nigrostriatal Pathway Loss in a Marmoset Model Treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Keigo Hikishima, Kiyoshi Ando, Ryutaro Yano et al. · Radiology · 2015 · 40 citations

Voxel-based morphometry of the marmoset brain: In vivo detection of volume loss in the substantia nigra of the MPTP-treated Parkinson’s disease model

Keigo Hikishima, Keiko Gengyo‐Ando, Yuji Komaki et al. · Neuroscience · 2015 · 29 citations

Volume Loss, Neuroimaging Biomarkers, Neurodegenerative Diseases +10